Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2

Xenobiotica; the Fate of Foreign Compounds in Biological Systems
V KukongviriyapanV Bhudhisawasdi

Abstract

Arylamine N-acetyltransferases (NAT) are important enzymes involved in the metabolic activation of aromatic and heterocyclic amines and inhibitors of NAT enzymes may be valuable as chemopreventive agents. Phytochemicals including cinnamic acid derivatives, various classes of flavonoids and coumarins were tested for the inhibitory activity on NAT1 and NAT2 from human liver and the human cholangiocarcinoma cell line: KMBC cells. Assays were performed using p-aminobenzoic acid and sulfamethazine as selective substrates for NAT1 and NAT2, respectively. NAT1 and NAT2 activities were present in liver cytosol. However, the KMBC cells showed only NAT1 activity. There was a marked difference in the ability of the test chemicals to inhibit NAT1 and NAT2. Caffeic acid, ferulic acid, gallic acid and EGCG inhibited NAT1 but not NAT2, whereas scopuletin and curcumin inhibited NAT2 but not NAT1. Quercetin, kaemferol and other flavonoids, except epicatechin and silymarin, inhibited both enzymes. The kinetics of inhibition of NAT1 by caffeic acid, EGCG and quercetin were of the non-competitive type, whereas that of NAT2 by quercetin, curcumin and kaemferol was also of the non-competitive type. The most potent inhibitor was quercetin, which has ...Continue Reading

References

Nov 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F LakehalC Housset
Mar 16, 2000·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·J G ChungY C Li
Apr 4, 2000·Toxicological Sciences : an Official Journal of the Society of Toxicology·K F WindmillM E McManus
Jan 11, 2001·European Journal of Clinical Pharmacology·I ErlundA Aro
Jun 9, 2001·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Y C LiJ G Chung
Mar 5, 2002·Pharmacogenetics·Naoko IshibeNathaniel Rothman
Mar 28, 2002·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·J Little, L Sharp
Apr 23, 2002·Pharmacogenomics·Frédérique PompeoEdith Sim
Jun 27, 2002·Biochemical and Biophysical Research Communications·Kumuda C Das, Chandan K Das
Mar 13, 2003·British Journal of Clinical Pharmacology·Veerapol KukongviriyapanBenjamart Warasiha
Jun 20, 2003·Cancer Causes & Control : CCC·Olga L van der HelPetra H M Peeters
Jun 24, 2003·The American Journal of Gastroenterology·Yi-Shin HuangShou-Dong Lee
Jul 11, 2003·Bioorganic & Medicinal Chemistry Letters·Edward W BrookeIsaac M Westwood
Jul 25, 2003·European Journal of Clinical Pharmacology·Veerapol KukongviriyapanJareerat Aiemsa-ard
Jun 9, 2004·Free Radical Biology & Medicine·Chi Chen, A-N Tony Kong
Jul 13, 2004·Archives of Biochemistry and Biophysics·V A KostyukI B Afanas'ev
Nov 13, 2004·Journal of Pharmacological Sciences·Hyun Pyo KimSam Sik Kang
May 20, 2005·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·A PrawanV Bhudhisawasdi
Aug 6, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R A SharmaW P Steward

❮ Previous
Next ❯

Citations

Jan 19, 2012·Chemical Communications : Chem Comm·Takuya TeraiTetsuo Nagano
Jul 30, 2010·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Petra JancovaEva Anzenbacherova
Mar 29, 2008·Expert Opinion on Drug Metabolism & Toxicology·Rainer Cermak
Jul 28, 2012·Toxicology·Dorothea DierolfBrunhilde Blömeke
Apr 8, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tonika BohnertUNKNOWN International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) Victim Drug-Drug Interactions Working
Nov 1, 2015·International Journal of Immunopathology and Pharmacology·I M TahirM Riaz
Mar 6, 2009·The American Journal of Clinical Nutrition·Sabine RohrmannJakob Linseisen
Jul 25, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Li-Zhi ChengYong-Xian Cheng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.